| Financial Year |
March 31 2023 |
| Monetary Funds |
591,832,720.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
514,711,654.38 |
| Advances to Suppliers |
174,922,125.11 |
| Other Receivables |
9,479,692.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
5,824.54 |
| Dividend Receivable |
-- |
| Inventories |
608,601,186.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
32,594,909.64 |
| Total Current Assets |
3,170,531,124.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
32,915,621.13 |
| Fixed Assetes |
1,722,763,951.25 |
| Under-construction Projects |
62,693,941.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
842,424,223.40 |
| R&D expenses |
57,532,316.69 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,835,680.91 |
| Deferred Income Tax Assets |
120,690,059.40 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,307,729,360.80 |
| Total Assets |
6,478,260,485.69 |
| Short-Term Loans |
56,655,728.70 |
| Trading Financial liabilities |
-- |
| Notes Payable |
529,829,852.51 |
| Accounts Payable |
811,673,164.09 |
| Accounts Received In Advance |
184,992.00 |
| Employee Compensation Payable |
65,919,932.10 |
| Taxes Payable |
76,984,708.80 |
| Interest Payable |
-- |
| Dividend Payable |
456,994.89 |
| Other payables |
763,996,266.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
54,587,997.85 |
| Other Current Liabilities |
4,875,825.09 |
| Sub-Total of Current Liabilities |
3,356,789,451.08 |
| Long-term Loans |
12,360,639.02 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
91,009,656.80 |
| Deferred Income Tax Liabilities |
1,428,432.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
180,040,307.52 |
| Total Liabilities |
3,536,829,758.60 |
| Paid-In Capital(Or Share Stock) |
1,644,636,426.00 |
| Capital Surplus |
3,768,418,185.38 |
| Surplus Reserve |
169,520,080.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,532,358,139.74 |
| Minority Stockholder's Interest |
893,125,393.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,048,305,333.41 |
| Owner's Equity（Stockholder's Equity） |
2,941,430,727.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,478,260,485.69 |
